Psychological Distress in Breast Cancer Patients: A Cross-Sectional Study in Iraq

August 5, 2025 updated by: Hameed Adnan Hameed

Psychosocial and Clinical Predictors of Depression, Anxiety, and Stress Among Breast Cancer Patients in Iraq: A Multivariate and Path Modeling Analysis

This cross-sectional study aims to assess the psychological distress, including depression, anxiety, and stress, among breast cancer patients in Anbar, Iraq. Data were collected using validated questionnaires to evaluate mental health status and associated clinical and demographic factors. The findings will provide insights to improve psychosocial support and patient care in oncology settings

Study Overview

Status

Completed

Conditions

Detailed Description

This research is a cross-sectional study conducted to investigate the prevalence and severity of psychological distress, including depression, anxiety, and stress, among breast cancer patients in Anbar, Iraq. The study utilized standardized and validated questionnaires (such as PHQ-9, GAD-7, and Perceived Stress Scale) to assess the mental health status of participants. Data on clinical variables, cancer stage, treatment modalities, and socio-demographic characteristics were collected to identify potential predictors of psychological distress. Statistical analyses were performed to explore associations between psychological outcomes and clinical or demographic factors. The results of this study aim to provide evidence to guide psychosocial interventions and enhance patient care strategies in oncology centers.

Study Type

Observational

Enrollment (Actual)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Iraq
    • Anbar
      • Ramadi, Anbar, Iraq, 31001
        • Anbar Oncology Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population consists of female breast cancer patients attending Anbar Cancer Center in Iraq for treatment or follow-up during the study period.

Description

Inclusion Criteria:

  • Diagnosed with breast cancer
  • Female patients aged ≥18 years
  • Receiving treatment or follow-up at Anbar Cancer Center
  • Willing to provide informed consent

Exclusion Criteria:

  • Severe cognitive impairment

    • Inability to complete questionnaires
    • Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Breast Cancer Patients Group
This group includes all female patients diagnosed with breast cancer who participated in the cross-sectional survey assessing depression, anxiety, and stress in Anbar, Iraq.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of Depression, Anxiety, and Sleep Disturbances among Breast Cancer Patients
Time Frame: 4 months (January 28, 2025 - May 30, 2025)
Assessment of psychological distress levels (depression, anxiety, and sleep quality) using PHQ-9, GAD-7, and Pittsburgh Sleep Quality Index questionnaires to evaluate mental health outcomes in breast cancer patients.
4 months (January 28, 2025 - May 30, 2025)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hameed Adnan Hameed

Investigators

  • Principal Investigator: Raghda Roshdy Sayed Hussein, PhD, Clinical pharmacy, Faculty of pharmacy, Beni-Suef University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 29, 2025

Primary Completion (Actual)

May 30, 2025

Study Completion (Actual)

May 30, 2025

Study Registration Dates

First Submitted

July 29, 2025

First Submitted That Met QC Criteria

August 5, 2025

First Posted (Actual)

August 7, 2025

Study Record Updates

Last Update Posted (Actual)

August 7, 2025

Last Update Submitted That Met QC Criteria

August 5, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BC-Psychology-2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared because the dataset contains sensitive patient information and there are no current agreements or resources to enable secure data sharing while ensuring confidentiality

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe